期刊文献+

川芎嗪对早期糖尿病肾病的治疗作用 被引量:6

EFFECTS OF LIGUSTRAZINE ON EARLY DIABETIC NEPHROPATHY
下载PDF
导出
摘要 ①目的 观察川芎嗪对早期糖尿病肾病 (DN)的治疗作用。②方法 早期DN病人 62例随机分为川芎嗪治疗组和对照组 ,对照组行饮食控制及应用胰岛素或糖适平控制血糖 ,治疗组在上述治疗基础上加川芎嗪治疗 ,共 4周。观察两组治疗前后血糖、血常规、血生化、肝功能、肾小球滤过率 (GFR)、尿清蛋白排泄率 (UAER)、血和尿 β2 微球蛋白 ( β2 MG)的变化及治疗过程中出现的副作用。③结果 治疗后两组病人血糖、GFR、UAER、血和尿 β2 MG与治疗前比较明显改善 (t=2 .917~ 5 .12 6,P <0 .0 5 ) ,而治疗组GFR、UAER、血 β2 MG改善优于对照组(t=2 .10 5~ 2 .864 ,P <0 .0 5 )。川芎嗪治疗过程中对病人无明显的副作用。④结论 川芎嗪对早期糖尿病肾病病人有明显疗效 。 Objective To observe the effects of Ligustrazine on early diabetic nephropathy(DN). Methods Sixty-two patients with early DN were randomly divided into control group (31 cases ,regular therapy) and treated group (31 cases ,regular therapy plus Ligustrazine). The course of treatment was 4 weeks. The glomerular filtration rate (GFR),urinary albumin excretion rate(UAER),blood and urine β 2-microglobulin(β 2-MG) were determined for both groups before and after the treatment, the side effects during the treatment were observed as well. Results Blood sugar, GFR, UAER, blood and urine β 2-MG were improved very much for the both groups after the treatment (t=2.917-5.126, P<0.05), but the treated group was much better than that of the control group in terms of GFR, UAER and blood β 2-MG (t=2.105-2.864, P<0.05). No obvious side effects were found by using Ligustrazine during the treatment. Conclusion Ligustrazine has a beneficial effect on early diabetic nephropathy.
出处 《齐鲁医学杂志》 2003年第1期46-47,共2页 Medical Journal of Qilu
关键词 川芎嗪 糖尿病肾病 肾小球滤过率 Ligustrazine diabetic nephropathy Ligustrazine glomerular filtration rate
  • 相关文献

参考文献5

  • 1[1]MogensenCE,Christensen CK,Vitinghus E. The stages in dia betic renal disease. With emphasis on the stage of incipient dia betic nephropathy[J]. Diabetes, 1983,32(Suppl 2) :64
  • 2[2]Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes[J]. N Engl J Med,1984,310(6) :356
  • 3[3]Bain R,Rohde R,Hunsichker LG,et al. A controlled clinical trial of angiotensinconverting enzyme inhibition in type I diabetic nephropathy:study design ang patient characteristics[J]. J Am Soc Nepgrol, 1992,3 ( Suppl 4 ): s97
  • 4[4]Orisio S. Gene polymorphism of the rennin-angiotensin system and progression of diabetic nephropathy[J]. J Nephrol,1999,10(1) :9
  • 5[5]Yotsumoto T, NalTOH, Shikada K,et al. Effects of specific an tagonists of angiotensin Iireceptors and captopril on diabetic ne phropathy in mice[J]. Jpn J Pharmacol, 1997,75(1):59

同被引文献98

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部